Pyridazinone derivatives useful as glucan synthase inhibitors

Details for Australian Patent Application No. 2008227100 (hide)

Owner SCHERING CORPORATION ALBANY MOLECULAR RESEARCH, INC.

Inventors Cao, Jianhua; Kuang, Rongze; Kim, David Won-Shik; Herr, Robert Jason; Zhou, Gang; Yang, Jinhai; Ting, Pauline C.; Zych, Andrew John; Zorn, Nicolas; Aslanian, Robert G.; Wu, Heping

Agent Griffith Hack

Pub. Number AU-A-2008227100

PCT Pub. Number WO2008/115381

Priority 60/918,171 15.03.07 US

Filing date 12 March 2008

Wipo publication date 25 September 2008

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 515/22 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/115381 Priority application(s): WO2008/115381

11 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.; Albany Molecular Research, Inc. Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008227102-Methods and apparatus for fabricating leads with conductors and related flexible lead configurations

2008227090-Amorphous drug transdermal systems, manufacturing methods, and stabilization